Cellebrite DI awarded director Van Buren Brandon 15,190 shares at $0 per share, taking his resulting holding to 50,744 shares. The award represents about 29.9% of that resulting holding, giving investors a precise measure of the transaction’s size within his post-award position.
Key Highlights
- Van Buren Brandon’s Cellebrite DI share award was priced at $0 per share.
- The director’s resulting Cellebrite DI holding stands at 50,744 shares.
- The transaction accounted for about 29.9% of Brandon’s resulting share position.
Director Receives Zero-Cost Share Award
Cellebrite DI Ltd. (NASDAQ: CLBT) is a packaged software company. The award took place on Sept. 17. Brandon’s resulting position was 50,744 Cellebrite DI shares after the transaction.
Award’s Share of Resulting Position
The 15,190-share transaction represented about 29.9% of Brandon’s resulting holding. That percentage measures the award against the shares he owned after the transaction.
FAQs
Q: How many Cellebrite DI shares did Van Buren Brandon receive?
A: Van Buren Brandon received 15,190 Cellebrite DI shares. The award was made at $0 per share.
Q: What was Van Buren Brandon’s resulting holding in Cellebrite DI?
A: Brandon’s resulting Cellebrite DI holding was 50,744 shares. He was identified as a director of the packaged software company.
Q: When did the Cellebrite DI share award occur?
A: The Cellebrite DI share award occurred on Sept. 17.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.